Eva Malirova
Hradec Kralove, KR, Czech Republic
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Analyses of biomarkers of exposure to nephrotoxic mycotoxins in a cohort of patients with renal tumours.
Journal: Mycotoxin research
Published: February 06, 2019
Analysis of preoperative serum levels of MMP1, -2, and -9 in patients with site-specific head and neck squamous cell cancer.
Journal: Anticancer research
Published: December 16, 2014
Urinary neopterin concentrations during combination therapy with cetuximab in previously treated patients with metastatic colorectal carcinoma.
Journal: In vivo (Athens, Greece)
Published: September 06, 2014
The role of urinary aldosterone for the diagnosis of primary aldosteronism.
Journal: Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme
Published: May 09, 2014
Hepatic arterial infusion of oxaliplatin, 5-fluorouracil and leucovorin in patients with liver metastases from colorectal carcinoma.
Journal: Journal of B.U.ON. : official journal of the Balkan Union of Oncology
Published: January 22, 2013
Hepatic arterial infusion of irinotecan, 5-Fluorouracil and leucovorin in patients with liver metastases from colorectal carcinoma.
Journal: Anticancer research
Published: December 11, 2012
Thyroid hormone abnormalities in hemodialyzed patients: low triiodothyronine as well as high reverse triiodothyronine are associated with increased mortality.
Journal: Physiological research
Published: August 14, 2012
Hypomagnesaemia in patients with metastatic colorectal carcinoma treated with cetuximab.
Journal: Hepato-gastroenterology
Published: February 23, 2012
Confirmatory testing in primary aldosteronism: extensive medication switching is not needed in all patients.
Journal: European journal of endocrinology
Published: January 19, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026